Insiders / Hamill Laura
Hamill Laura
CIK 1751804personinsider
Companies
7
First seen
Feb 2, 2021
Last activity
Aug 7, 2026
Holdings
7 companies · 5 positionsView all →
| Company / security | Shares held | Latest |
|---|---|---|
| Scilex Holding Co · SCLX | — | — |
| Options | 250,000 | Jan 17, 2023 |
| Fate Therapeutics Inc · FATE | — | — |
| Options | 175,800 | Jun 12, 2026 |
| Anaptysbio, Inc · ANAB | — | — |
| Restricted units | 3,900 | Jan 6, 2023 |
| Options | 10,600 | Jan 6, 2023 |
| Jazz Pharmaceuticals plc · JAZZ | 8,538 | — |
| Ordinary shares | 8,538 | Aug 5, 2026 |
| Acceleron Pharma Inc · XLRN | 0 | — |
| Pardes Biosciences, Inc. · FSII | — | — |
| Y-mAbs Therapeutics, Inc. · YMAB | 0 | — |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Aug 8, 2025 | Other Withheld for taxes | JAZZ Jazz Pharmaceuticals plc Ordinary Shares | $200.8K | -2K -20.66% | 6,933 0.01% of shares | low |
| Sep 16, 2025 | Other Shares tendered | YMAB Y-mAbs Therapeutics, Inc. Common Stock | $50.1K | -6K -100.00% | 0 | low |
| Jun 30, 2025 | Grant Grant or award | YMAB Y-mAbs Therapeutics, Inc. Common Stock | $0 |